Skip to main content
SpringerLink
Log in

Preparation and preliminary bioevaluation of 68Ga-oxine in lipiodol as a potential liver imaging agent

  • Published:
Journal of Radioanalytical and Nuclear Chemistry Aims and scope Submit manuscript

Abstract

Lipiodol functions as an embolizing agent for trans-arterial embolization and is used to deliver localized doses of chemotherapeutic drugs as well as ionizing radiation to cancerous tissue of the liver. Therefore, an attempt was made to prepare 68Ga-labeled lipiodol, which may have potential as a PET radiotracer for imaging of liver cancer. 68Ga-labeled lipiodol was prepared by a two-step procedure involving formation of highly lipophilic 68Ga-oxine complex followed by its dispersion in lipiodol. Preliminary biological evaluation in normal Wistar rats revealed satisfactory hepatic retention with insignificant uptake in any other major organ/tissue indicating promising potential of the agent.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  Google Scholar 

  2. El-Serag HB (2011) Hepatocellular carcinoma. N Engl J Med 365:1118–1127

    Article  CAS  Google Scholar 

  3. Ibrahim SM, Lewandowski RJ, Sato KT, Gates VL, Kulik L, Mulcahy MF, Ryu RK, Omary RA, Salem R (2008) Radioembolization for the treatment of unresectable hepatocellular carcinoma: a clinical review. World J Gastroenterol 14:1664–1669

    Article  Google Scholar 

  4. Wang CC, Li J (2012) An update on chemotherapy of colorectal liver metastases. World J Gastroenterol 18:25–33

    Article  CAS  Google Scholar 

  5. Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405–1410

    Article  CAS  Google Scholar 

  6. Brito AF, Mendes M, Abrantes AM, Tralhão JG, Botelho MF (2014) Positron emission tomography diagnostic imaging in multidrug-resistant hepatocellular carcinoma: focus on 2-deoxy-2-(18F)fluoro-d-glucose. Mol Diagn Ther 18:495–504

    Article  CAS  Google Scholar 

  7. Tenley N, Corn DJ, Yuan L, Lee Z (2013) The effect of fasting on PET imaging of hepatocellular carcinoma. J Cancer Ther 4:561–567

    Article  Google Scholar 

  8. Jo IY, Son SH, Kim M, Sung SY, Won YK, Kang HJ, Lee SJ, Chung YA, Oh JK, Kay CS (2015) Prognostic value of pretreatment 18F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma. Radiat Oncol J 33:179–187

    Article  Google Scholar 

  9. Velikyan I (2014) Prospective of 68Ga-radiopharmaceutical development. Theranostics 4(1):47–80

    Article  CAS  Google Scholar 

  10. Banerjee SR, Pomper MG (2013) Clinical applications of gallium-68. Appl Radiat Isot 76:2–13

    Article  CAS  Google Scholar 

  11. Rösch F (2013) 68Ge/68Ga generators: past, present, and future. Recent Results Can Res 194:3–16

    Article  Google Scholar 

  12. Roesch F, Riss PJ (2010) The renaissance of the 68Ge/68Ga radionuclide generator initiates new developments in 68Ga radiopharmaceutical chemistry. Curr Top Med Chem 10:1633–1668

    Article  CAS  Google Scholar 

  13. Idée JM, Guiu B (2013) Use of lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review. Crit Rev Oncol Hematol 88:530–549

    Article  Google Scholar 

  14. Groupe d’Etude et de Traitement du Carcinome Hépatocellulaire (1995) A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 32:1256–1261

    Google Scholar 

  15. Lo CM, Ngan H, Tso WK, Liu CL, Lam CM, Poon RTP, Fan ST, Wong J (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164–1171

    Article  CAS  Google Scholar 

  16. Jeong JM, Kim YJ, Lee YS, Ko JI, Son M, Lee DS, Chung JK, Park JH, Lee MC (2001) Lipiodol solution of a lipophilic agent 188Re-TDD for the treatment of liver cancer. Nucl Med Biol 28:197–204

    Article  CAS  Google Scholar 

  17. Taylor I, Bennett R, Sherriff S (1978) The blood supply of colorectal liver metastases. Br J Cancer 38:749–756

    Article  CAS  Google Scholar 

  18. Scartozzi M, Baroni GS, Faloppi L, Paolo MDP, Pierantoni C, Candelari R, Berardi R, Antognoli S, Mincarelli C, Risaliti A, Marmorale C, Antico E, Benedetti A, Cascinu S (2010) Trans-arterial chemo-embolization (TACE), with either lipiodol (traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis. J Exp Clin Cancer Res 29:164

    Article  Google Scholar 

  19. Park CH, Suh JH, Yoo HS, Lee JT, Kim DI, Kim BS (1987) Treatment of hepatocellular carcinoma (HCC) with radiolabeled lipiodol: a preliminary report. Nucl Med Commun 8:1075–1087

    Article  CAS  Google Scholar 

  20. Das T, Chakraborty S, Sarma HD, Venkatesh M, Banerjee S (2009) Preparation of 166Ho-oxine-lipiodol and its preliminary bioevaluation for the potential application in therapy of liver cancer. Nucl Med Commun 30:362–367

    Article  Google Scholar 

  21. Yu J, Häfeli UO, Sands M, Dong Y (2003) 90Y-oxine-ethiodol, a potential radiopharmaceutical for the treatment of liver cancer. Appl Radiat Isot 58:567–573

    Article  CAS  Google Scholar 

  22. Ellis BL, Sharma HL (1999) Co, Fe and Ga chelates for cell labelling: a potential use in PET imaging? Nucl Med Commun 20:1017–1021

    Article  CAS  Google Scholar 

  23. Subramanian S, Das T, Chakraborty S, Sarma HD, Banerjee S, Samuel G, Venkatesh M (2010) Preparation of 177Lu-labeled oxine in lipiodol as a possible agent for therapy of hepatocellular carcinoma: a preliminary animal study. Cancer Biother Radiopharm 25:539–543

    Article  CAS  Google Scholar 

  24. Das T, Bhadwal M, Sarma HD, Banerjee S (2014) Formulation and radiochemical evaluation of a freeze-dried mixed peptide kit for the preparation of 68Ga-labeled peptides for PET imaging of somatostatin receptor positive neuroendocrine cancers. J Radioanal Nucl Chem 302:1259–1264

    Article  CAS  Google Scholar 

  25. Bhadwal M, Das T, Sarma HD, Banerjee S (2015) Radiosynthesis and bioevaluation of [68Ga]-labeled 5,10,15,20-tetra(4-methylpyridyl)-porphyrin for possible application as a PET radiotracer for tumor imaging. Mol Imaging Biol 17:111–118

    Article  CAS  Google Scholar 

  26. Das T, Sarma HD, Shinto A, Kamaleshwaran KK, Banerjee S (2014) Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP. Cancer Biother Radiopharm 29:412–421

    Article  CAS  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Dr. Vikram R. Lele, Director, Department of Nuclear Medicine, Jaslok Hospital and Research Centre, Mumbai for providing the 68Ge/68Ga generator used in the present study. The authors acknowledge Dr. K. L. Ramakumar, Director, Radiochemistry and Isotope group, Bhabha Atomic Research Centre (BARC), Mumbai for his support and encouragement. The help rendered by the staff members of Laboratory Animal House Facility of Radiation Biology and Health Sciences Divisions, BARC is also thankfully acknowledged.

Author information

Authors and Affiliations

  1. Radiopharmaceuticals Chemistry Section, Radiochemistry and Isotope Group, Bhabha Atomic Research Centre, Trombay, Mumbai, 400 085, India

    Subhajit Ghosh, Tapas Das & Sharmila Banerjee

  2. Homi Bhabha National Institute, Anushaktinagar, Mumbai, 400 094, India

    Tapas Das & Sharmila Banerjee

  3. Radiation Biology and Health Sciences Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400 085, India

    Haladhar D. Sarma

Authors
  1. Subhajit Ghosh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tapas Das
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haladhar D. Sarma
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sharmila Banerjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tapas Das.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ghosh, S., Das, T., Sarma, H.D. et al. Preparation and preliminary bioevaluation of 68Ga-oxine in lipiodol as a potential liver imaging agent. J Radioanal Nucl Chem 311, 263–268 (2017). https://doi.org/10.1007/s10967-016-4985-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10967-016-4985-0

Keywords

Search

Navigation